Ex vivo transduction of human dermal tissue structures for autologous implantation production and delivery of therapeutic proteins
Open Access
- 1 August 2005
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 12 (2) , 274-282
- https://doi.org/10.1016/j.ymthe.2005.03.023
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Survival of Encapsulated Human Primary Fibroblasts and Erythropoietin Expression Under Xenogeneic ConditionsHuman Gene Therapy, 2004
- Immune responses against adenoviral vectors and their transgene products: a review of strategies for evasionCritical Reviews in Oncology/Hematology, 2004
- Lentivectors for Regulated and Reversible Cutaneous Gene DeliveryMolecular Therapy, 2004
- Liver micro-organs transcribe albumin and clotting factors and increase survival of 92% hepatectomized ratsJournal of Hepatology, 2003
- Improved capillary isoelectric focusing method for recombinant erythropoietin analysisJournal of Chromatography A, 2002
- Long-Term Doxycycline-Regulated Secretion of Erythropoietin by Encapsulated MyoblastsMolecular Therapy, 2002
- Sustainable Systemic Delivery via a Single Injection of Lentivirus into Human Skin TissueHuman Gene Therapy, 2001
- Encapsulation for Somatic Gene TherapyAnnals of the New York Academy of Sciences, 1999
- Improvement of mouse β-thalassemia upon erythropoietin delivery by encapsulated myoblastsGene Therapy, 1999
- State of the Art Lecture: Historical review on the use of recombinant human erythropoietin in chronic renal failureNephrology Dialysis Transplantation, 1995